CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +20,000 | $4.20 | $84K | 430,958 |
| 2022-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −20,000 | $15.88 | $318K | 410,958 |
| 2022-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion · Option (right to buy) | −20,000 | 20,000 | ||
| 2022-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −7,177 | $16.71 | $120K | 410,958 |
| 2022-08-03 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +28,950 | 425,312 | ||
| 2022-08-03 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −7,177 | $21.49 | $154K | 418,135 |
| 2022-05-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −6,123 | $20.08 | $123K | 396,362 |
| 2022-03-04 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +59,490 | 402,485 | ||
| 2022-02-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −2,526 | $18.59 | $47K | 360,646 |
| 2022-02-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −17,651 | $18.59 | $328K | 342,995 |
| 2021-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Grant or award | +18,741 | 367,818 | ||
| 2021-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −4,646 | $17.00 | $79K | 363,172 |
| 2021-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +47,500 | $6.21 | $295K | 410,672 |
| 2021-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −47,500 | $17.44 | $828K | 363,172 |
| 2021-12-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion · Option (right to buy) | −47,500 | 0 | ||
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Exercise or conversion | +47,500 | $6.21 | $295K | 458,740 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Sale | −47,500 | $18.09 | $859K | 411,240 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −6,818 | $18.10 | $123K | 404,422 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −2,323 | $18.10 | $42K | 402,099 |
| 2021-11-15 | Lamb Peter EVP, Scientific Strategy & CSO | Shares withheld for taxes | −53,022 | $18.10 | $960K | 349,077 |
Page 1 of 4 · 65 trades